Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07470138

Sleep Disturbance in Subjects With Autism Spectrum Disorders (ASD) in Preschool Age (18-60 Months)

Disturbo Del Sonno in Soggetti Con Disturbi Dello Spettro Dell'Autismo (ASD) in età Prescolare (18-60 Mesi)

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
IRCCS Eugenio Medea · Academic / Other
Sex
All
Age
18 Months – 60 Months
Healthy volunteers
Not accepted

Summary

An observational study is one that aims to collect data from routine clinical practice, without altering a patient's standard diagnostic and therapeutic pathway (no additional instrumental or laboratory tests beyond those performed in clinical practice are envisaged). The overall objective of this study is to investigate sleep disorders in preschool-aged children with Autism Spectrum Disorder. Sleep plays a key role in early brain development. The prevalence of sleep disorders in childhood is reported to be between 10 and 50%, with a prevalence of up to 86% in children with neurodevelopmental disorders. Over the past few decades, numerous studies have demonstrated a significant bidirectional connection between sleep problems and various areas of child development. Therefore, early identification of sleep disorders in childhood is essential for adequate treatment and prevention of negative cognitive and socioemotional impacts. Recent studies have demonstrated a hypothetical role for vitamin D and iron in regulating sleep. The objectives of the study are to describe sleep disturbances in a group of preschool-aged subjects with ASD (18-60 months), to measure blood ferritin and vitamin D levels, and to assess a possible correlation with specific subtypes of sleep disturbances. Given the impact that sleep disturbances have on various areas of children's development, secondary objectives include assessing a possible positive correlation between the severity of sleep disturbances and symptoms related to Autism Spectrum Disorder and/or other psychiatric comorbidities.

Conditions

Interventions

TypeNameDescription
OTHERfollow upclinical evaluation as usual

Timeline

Start date
2025-01-08
Primary completion
2026-12-15
Completion
2026-12-15
First posted
2026-03-13
Last updated
2026-03-24

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT07470138. Inclusion in this directory is not an endorsement.